ДИУРЕТИКИ В ЛЕЧЕНИИ ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ
Об авторах
М. А. ГуревичРоссия
факультет усовершенствования врачей – кафедра терапии
Л. В. Архипова
Россия
факультет усовершенствования врачей – кафедра терапии
В. И. Бувальцев
Россия
факультет усовершенствования врачей – кафедра терапии
Список литературы
1. Boдke T., Achhammer I. Torasemide: review of pharmacology and therapeutic use//Drugs Today. 1994; 30: 8: 1-28.
2. Friedel H., Buckley M. Torasemide. A review of pharmacological properties and therapeutic potential//Drugs 1991; 41:1:81-103.
3. Brunner G., von Bergmann K., Hacker W., et al. Comparison of diuretic effects and pharmacokinetics of torasemid and furosemid after a single oral dose in patients with hydropically decompensated cirrhosis of the liver//Arzt-Forsch. Drug Res 1998; 38: 176-179.
4. Reyes A. Effects of diuretics on outputs and flows or urine and urinary solutes in healthy subjects//Drugs 1991; 41: Suppl. 3: 35-59.
5. Patterson J., Adams K., Applefeld M., et al. Oral torasemide in patients with chronic congestive heart failure: effects on body weight, edema, and electrolyte excretion. Torasemide Investigators Group//Pharmacotherapy 1994; 14: 5: 514-521.
6. Cosin J., Diez J. and TORIC investigators. Torasemide in chronic heart failure: results of the TORIC study//Eur. J. Heart Fail. 2002; 4: 4: 507-513.
7. Yamato M., Sasaki T., Honda K., et al. Effects of torasemide on left ventricular function and neurohumoral factors in patients with chronic heart failure//Circulat. J. 2003; 67: 5: 384-390
8. Murray M., Deer M., Ferguson J., et al. Open-label randomized trial of torasemide compared with furosemide therapy for patients with heart failure//Am. J. Med. 2001; 111: 7: 5130520.
9. Spannheimer A., Muller K., Falkenstein P., et al. Long-term diuretic treatment in heart failure: are there differences between furosemide and torasemide?//Schweiz. Rundsch. Med. Prax. 2002; 91: 37: 14671475.
10. Muller K., Gamba G., Jaguet F., et al. Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA II to IV -efficacy and guality of life//Eur. J. Heart Fail. 2003; 5: 6: 793801.
11. Vargo D.L., Kramer W.G., Black P.K., et al. Bioavailiability, pharmacokinetics and pharmacodynamics of torasemide and furosemide in patients with congestive heart failure//Clin. Pharmacol. Ther. 1995; 57: 6: 601-609.
12. Guidelines for the diagnosis and treatment Chronic Heart Failure: full text (update 2005), The Task Force for the diagnosis and treatment of CHF of the European Society of Cardiology.
13. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of chronic heart Failure in the Adult.
Рецензия
Для цитирования:
Гуревич М.А., Архипова Л.В., Бувальцев В.И. ДИУРЕТИКИ В ЛЕЧЕНИИ ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ. Российский кардиологический журнал. 2008;(3):76-81.
For citation:
Gurevich M.A., Arkhipova L.V., Buvaltsev V.I. Diuretics in chronic heart failure management. Russian Journal of Cardiology. 2008;(3):76-81. (In Russ.)